Literature DB >> 23208112

Prion disease: diagnostic value of cerebrospinal fluid markers.

Piero Parchi, Sabina Capellari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23208112     DOI： 10.1038/nrneurol.2012.253

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

3.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

4.  Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Taim Muayqil; Gary Gronseth; Richard Camicioli
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

5.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

Review 6.  Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.

Authors:  Piero Parchi; Rosaria Strammiello; Armin Giese; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2010-11-24       Impact factor: 17.088

7.  Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.

Authors:  Wen-Quan Zou; Gianfranco Puoti; Xiangzhu Xiao; Jue Yuan; Liuting Qing; Ignazio Cali; Miyuki Shimoji; Jan P M Langeveld; Rudy Castellani; Silvio Notari; Barbara Crain; Robert E Schmidt; Michael Geschwind; Stephen J Dearmond; Nigel J Cairns; Dennis Dickson; Lawrence Honig; Juan Maria Torres; James Mastrianni; Sabina Capellari; Giorgio Giaccone; Ermias D Belay; Lawrence B Schonberger; Mark Cohen; George Perry; Qingzhong Kong; Piero Parchi; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

8.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.

Authors:  Michael D Geschwind; Jennifer Martindale; Deborah Miller; Stephen J DeArmond; Jane Uyehara-Lock; David Gaskin; Joel H Kramer; Nicholas M Barbaro; Bruce L Miller
Journal:  Arch Neurol       Date:  2003-06

9.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Authors:  Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis; Jerzy Kulczycki; Dana Slivarichova; Albert Saiz; Miguel Calero; Richard Knight; Adriano Aguzzi; Jean-Louis Laplanche; Katell Peoc'h; Gabi Schelzke; Andre Karch; Cornelia M van Duijn; Inga Zerr
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

10.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501
  10 in total
  5 in total

1.  Wait and see: a 5 year history of 'recurrent dementia'.

Authors:  Roberto D'Angelo; Rita Rinaldi; Piero Parchi; Fabio Cirignotta
Journal:  BMJ Case Rep       Date:  2014-11-19

2.  Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.

Authors:  Samir Abu Rumeileh; Francesca Lattanzio; Michelangelo Stanzani Maserati; Romana Rizzi; Sabina Capellari; Piero Parchi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.

Authors:  Niccolò Candelise; Simone Baiardi; Alessia Franceschini; Marcello Rossi; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2020-07-25       Impact factor: 7.801

4.  Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion Diseases.

Authors:  Cao Chen; Chao Hu; Qi Shi; Wei Zhou; Kang Xiao; Yuan Wang; Lian Liu; Jia Chen; Ying Xia; Xiao-Ping Dong
Journal:  Front Neurosci       Date:  2019-09-04       Impact factor: 4.677

5.  Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.

Authors:  Maxime Bélondrade; Simon Nicot; Charly Mayran; Lilian Bruyere-Ostells; Florian Almela; Michele A Di Bari; Etienne Levavasseur; Joel C Watts; Chantal Fournier-Wirth; Sylvain Lehmann; Stéphane Haïk; Romolo Nonno; Daisy Bougard
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.